Policy Memo
Topline
Congress should end the tax penalty against American companies that conduct research and development (R&D) outside the United States, except for in countries of concern like China.
Affordability 101 · Chapter 5: Freedom to Innovate and Compete
Plymouth Institute for Free Enterprise
Congress should end the tax penalty against American companies that conduct research and development (R&D) outside the United States, except for in countries of concern like China.
Full and immediate deductions of legitimate business expenses ensure that companies pay taxes only on their profits. Deviations from full deductibility of valid expenses are problematic, as they can cause unprofitable companies to be taxed as though they were profitable.
Prior to 2022, businesses could immediately deduct R&D expenditures, as they can most other legitimate business expenses. Then, Congress allowed a delayed provision of the 2017 Tax Cuts and Jobs Act to take effect, which put in place 5-year amortization for domestic R&D and 15-year amortization for R&D conducted outside the United States. Companies that incurred domestic R&D costs could only deduct 20% of the expense per year over a 5-year period. Companies that incurred foreign R&D costs could deduct only about 6.7% of the expense per year over a 15-year period. The One Big Beautiful Bill fixed the domestic R&D provision, once again allowing full and immediate expensing, but the 15-year amortization of foreign R&D was left in place.
There’s no good economic justification for the tax code penalizing companies for conducting R&D. Congress should unleash more development of new and innovative products at lower costs by scrapping this misguided policy.
This memo is part of Affordability 101, Advancing American Freedom’s playbook of 101 policy solutions to make life more affordable.